Cargando…
Reply: Potential role of Janus kinase inhibitors in COVID-19
Autores principales: | Napolitano, Maddalena, Fabbrocini, Gabriella, Patruno, Cataldo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American Academy of Dermatology, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195037/ https://www.ncbi.nlm.nih.gov/pubmed/32339701 http://dx.doi.org/10.1016/j.jaad.2020.04.098 |
Ejemplares similares
-
Reply: Calm before the storm: Understanding the role of Janus kinase inhibitors in COVID-19
por: Peterson, Danielle, et al.
Publicado: (2020) -
Patients with advanced basal cell carcinomas in treatment with sonic hedgehog inhibitors during the coronavirus disease 2019 (COVID-19) period: Management and adherence to treatment
por: Villani, Alessia, et al.
Publicado: (2020) -
Hydroxychloroquine and ivermectin: A synergistic combination for COVID-19 chemoprophylaxis and treatment?
por: Patrì, Angela, et al.
Publicado: (2020) -
The use of Janus kinase inhibitors in the time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
por: Peterson, Danielle, et al.
Publicado: (2020) -
Reply to: “Reply: A dermatologic manifestation of COVID-19: Transient livedo reticularis”
por: Manalo, Iviensan F., et al.
Publicado: (2020)